ProShare Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-34,175
Closed -$105K 2360
2021
Q4
$105K Buy
34,175
+1,179
+4% +$3.97K ﹤0.01% 2199
2021
Q3
$119K Sell
32,996
-8,873
-21% -$33.5K ﹤0.01% 1892
2021
Q2
$150K Buy
41,869
+3,900
+10% +$13.8K ﹤0.01% 2218
2021
Q1
$148K Buy
37,969
+2,485
+7% +$10.3K ﹤0.01% 2110
2020
Q4
$149K Buy
35,484
+8,218
+30% +$31.7K ﹤0.01% 1923
2020
Q3
$102K Sell
27,266
-767
-3% -$3.26K ﹤0.01% 1525
2020
Q2
$122K Buy
28,033
+10,772
+62% +$48.4K ﹤0.01% 1545
2020
Q1
$65K Sell
17,261
-13,506
-44% -$66.4K ﹤0.01% 1106
2019
Q4
$194K Buy
+30,767
New +$181K ﹤0.01% 1600
2014
Q4
Sell
-16,621
Closed -$284K 2338
2014
Q3
$284K Sell
16,621
-3,772
-18% -$54.7K ﹤0.01% 1761
2014
Q2
$246K Sell
20,393
-17,290
-46% -$164K ﹤0.01% 2045
2014
Q1
$318K Buy
+37,683
New +$304K ﹤0.01% 2204
2013
Q4
Sell
-18,900
Closed -$103K 2501
2013
Q3
$103K Buy
18,900
+1,380
+8% +$6.63K ﹤0.01% 2411
2013
Q2
$71K Buy
+17,520
New +$82.2K ﹤0.01% 2320

Other funds holding BDSI

ProShare Advisors's BDSI Position: Q1 2022 in Review

ProShare Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 34,175 shares — an estimated $105K sold.

ProShare Advisors first reported a position in BDSI in Q2 2013 and held it in 14 quarters. The position peaked at $318K in Q1 2014. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • ProShare Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • ProShare Advisors sold 34,175 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $105K.
  • ProShare Advisors first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 14 quarters.
  • ProShare Advisors's BioDelivery Sciences International, Inc. position peaked at $318K in Q1 2014.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.